FREE Case Review (866) 588-0600

Zantac Lawsuit

U.S. and European health agencies recently issued a warning that the heartburn medicine Zantac (generic: ranitidine) contains the cancer-causing chemical NDMA.

If you or a loved one were diagnosed with cancer after taking Zantac, you may be entitled to compensation by filing a Zantac lawsuit and our lawyers can help.

The FDA issued a warning that the popular heartburn drug Zantac had been found to contain N-nitrosodimethylamine, or NDMA, a known human carcinogen (cancer-causing substance).

This warning came after a pharmacy in Connecticut discovered elevated levels of NDMA while testing Zantac. It has been reported that the levels of cancer-causing NDMA are anywhere from 3,000 to 26,000 times higher than the legally allowable limit set by the FDA.

If you have been diagnosed with cancer after taking Zantac, you are not alone. Our lawyers have been contacted by hundreds of cancer victims who developed various forms of cancer after taking Zantac.

Free Zantac Lawsuit Review
If you or a loved one was diagnosed with cancer after taking Zantac, you should contact our law firm immediately.

You may be entitled to compensation by filing a Zantac lawsuit and we can help. Please click the button below for a Free Confidential Case Evaluation or call us toll-free 24 hrs/day by dialing (866) 588-0600.

Start My Free Case Review

What is Zantac?

Zantac belongs to a group of medicines known as histamine-2 blockers that work by reducing the amount of acid your stomach produces, according to WebMD. Ranitidine is used to treat ulcers in the stomach and/or intestines, and also to prevent conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome and gastroesophageal reflux disease (GERD). Zantac is manufactured and marketed by Sanofi, a French multinational pharmaceutical company headquartered in Paris.

What’s the problem?

Global health regulators in Europe and the United States have begun to warn that Zantac contains a cancer-causing ingredient called NDMA. The Zantac warning came after a pharmacy in Connecticut discovered elevated levels of NDMA while testing Zantac.

It has been reported that the levels of cancer-causing NDMA are anywhere from 3,000 to 26,000 times higher than the legally allowable limit set by the FDA.

Zantac Recall

Has Zantac been recalled? No. To date, Sanofi has not issued a recall for Zantac over the issue of potential NDMA contamination. But Valisure, a New Haven, Connecticut-based pharmacy has petitioned the FDA to recall Zantac after the discovery of NDMA adulteration.

The FDA has however recently recalled other drugs due to NDMA contamination. These medications called Angiotensin II Receptor Blockers (ARBs) are used to treat blood pressure issues and heart failure. The agency has issued numerous recalls for NDMA contaminated ARBs including Valsartan, Diovan, Losartan, and Irbesartan.

Zantac Side Effects

Our lawyers are reviewing potential lawsuits for people who developed any form of cancer after taking Zantac:

  • Liver cancer
  • Kidney cancer
  • Lung cancer
  • Intestinal cancer
  • Stomach cancer
  • Pancreatic cancer
  • Colon cancer
  • Ovarian cancer
  • Esophageal cancer
  • Testicular Cancer
  • And more

What is NDMA?

N-nitrosodimethylamine is a semi-volatile organic chemical that belongs to a class of known potent carcinogens, according to the U.S. Environmental Protection Agency (EPA). The chemical is used in gasoline, as a stabilizer for industry materials, and as a lubricant additive. NDMA has also been used to make liquid rocket fuel, and is a byproduct of manufacturing certain pesticides and processing fish.

How Do Our Prescription Drugs Get Contaminated?

FDA’s investigation highlights the challenge federal regulators face when dealing with a global pharmaceutical industry that exports generic drugs from dozens of countries, nearly all of which follow vastly different processes in bringing their products to market, according to Bloomberg. Several of the medications recently found to be contaminated with NDMA are from China and India, raising questions about the safety protocol for drug-makers in those countries. Poor quality control and efforts to conceal manufacturing problems from U.S. health regulators have complicated oversight of pharmaceutical companies overseas.

How Carcinogens Got Into the Generic U.S. Drug Supply: Bloomberg Video

FDA Recommendation

If you take Zantac, FDA is advising you to consult your physician with concerns about potential NDMA contamination, as well as your risk for getting cancer from the medication. Do not stop taking Zantac without talking to your doctor first, as doing so could also lead to serious side effects and/or adverse reactions.

Can I File a Class Action?

Although Schmidt & Clark, LLP, is a nationally recognized class action firm, we have decided against this type of litigation when it comes to pursuing Zantac lawsuits. Our lawyers feel that if there is a successful resolution to these cases, individual suits, not class actions will be the best way to get maximum payouts to our clients.

If you’ve been injured by Zantac, we know you’ve suffered emotionally and economically, and want to work with you personally to obtain the maximum compensation for the damages caused by your injuries. Contact us today to learn more about your legal rights.

Do I Have a Zantac Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zantac lawsuits. We are handling individual litigation nationwide and currently accepting new Zantac induced cancer cases in all 50 states.

Again, If you or a loved one was diagnosed with cancer after taking Zantac, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition